Literature DB >> 33411411

Hypoalbuminemia in COVID-19: assessing the hypothesis for underlying pulmonary capillary leakage.

M A Wu1, T Fossali2, L Pandolfi3, L Carsana4, D Ottolina2, V Frangipane3, R Rech2, A Tosoni4, G Lopez4, A Agarossi2, C Cogliati1, F Meloni5,6, B Marchini7, M Nebuloni4,7, E Catena2, R Colombo2.   

Abstract

BACKGROUND: Since the first observations of patients with COVID-19, significant hypoalbuminaemia was detected. Its causes have not been investigated yet.
OBJECTIVE: We hypothesized that pulmonary capillary leakage affects the severity of respiratory failure, causing a shift of fluids and proteins through the epithelial-endothelial barrier.
METHODS: One hundred seventy-four COVID-19 patients with respiratory symptoms, 92 admitted to the intermediate medicine ward (IMW) and 82 to the intensive care unit (ICU) at Luigi Sacco Hospital in Milan, were studied.
RESULTS: Baseline characteristics at admission were considered. Proteins, interleukin 8 (IL-8) and interleukin 10 (IL-10) in bronchoalveolar lavage fluid (BALF) were analysed in 26 ICU patients. In addition, ten autopsy ultrastructural lung studies were performed in patients with COVID-19 and compared with postmortem findings in a control group (bacterial pneumonia-ARDS and H1N1-ARDS). ICU patients had lower serum albumin than IMW patients [20 (18-23) vs 28 (24-33) g L-1 , P < 0.001]. Serum albumin was lower in more compromised groups (lower PaO2 -to-FiO2 ratio and worst chest X-ray findings) and was associated with 30 days of probability of survival. Protein concentration was correlated with IL-8 and IL-10 levels in BALF. Electron microscopy examinations of eight out of ten COVID-19 lung tissues showed loosening of junctional complexes, quantitatively more pronounced than in controls, and direct viral infection of type 2 pneumocytes and endothelial cells.
CONCLUSION: Hypoalbuminaemia may serve as severity marker of epithelial-endothelial damage in patients with COVID-19. There are clues that pulmonary capillary leak syndrome plays a key role in the pathogenesis of COVID-19 and might be a potential therapeutic target.
© 2021 The Association for the Publication of the Journal of Internal Medicine.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; capillary leakage; capillary permeability; critical care; hypoalbuminaemia

Mesh:

Substances:

Year:  2021        PMID: 33411411     DOI: 10.1111/joim.13208

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  12 in total

1.  Identification of bronchoalveolar and blood immune-inflammatory biomarker signature associated with poor 28-day outcome in critically ill COVID-19 patients.

Authors:  Guy Gorochov; Muriel Fartoukh; Guillaume Voiriot; Karim Dorgham; Guillaume Bachelot; Anne Fajac; Laurence Morand-Joubert; Christophe Parizot; Grigorios Gerotziafas; Dominique Farabos; Germain Trugnan; Thibaut Eguether; Clarisse Blayau; Michel Djibré; Alexandre Elabbadi; Aude Gibelin; Vincent Labbé; Antoine Parrot; Matthieu Turpin; Jacques Cadranel; Antonin Lamazière
Journal:  Sci Rep       Date:  2022-06-09       Impact factor: 4.996

Review 2.  Mesenchymal stromal cell secretome in liver failure: Perspectives on COVID-19 infection treatment.

Authors:  Cinzia Maria Chinnici; Giovanna Russelli; Matteo Bulati; Vitale Miceli; Alessia Gallo; Rosalia Busà; Rosaria Tinnirello; Pier Giulio Conaldi; Gioacchin Iannolo
Journal:  World J Gastroenterol       Date:  2021-05-07       Impact factor: 5.742

3.  Clinical-radiological correlations in COVID-19-related venous thromboembolism: Preliminary results from a multidisciplinary study.

Authors:  Maddalena Alessandra Wu; Riccardo Colombo; Massimo Arquati; Sonia Ippolito; Alba Taino; Diego Ruggiero; Francesca Tonelli; Lucia Trombetta; Pietro Facchinetti; Pierluigi Glielmo; Chiara Cogliati; Nicola Flor
Journal:  Int J Clin Pract       Date:  2021-05-29       Impact factor: 3.149

4.  Plasma Proteome Fingerprints Reveal Distinctiveness and Clinical Outcome of SARS-CoV-2 Infection.

Authors:  Wolfgang Bauer; Marcus Weber; Eva Diehl-Wiesenecker; Noa Galtung; Monika Prpic; Rajan Somasundaram; Rudolf Tauber; Jochen M Schwenk; Patrick Micke; Kai Kappert
Journal:  Viruses       Date:  2021-12-07       Impact factor: 5.048

5.  Direct comparison of different therapeutic cell types susceptibility to inflammatory cytokines associated with COVID-19 acute lung injury.

Authors:  Ramana Vaka; Saad Khan; Bin Ye; Yousef Risha; Sandrine Parent; David Courtman; Duncan J Stewart; Darryl R Davis
Journal:  Stem Cell Res Ther       Date:  2022-01-15       Impact factor: 6.832

6.  Lung histopathologic clusters in severe COVID-19: a link between clinical picture and tissue damage.

Authors:  Maddalena Alessandra Wu; Gianluca Lopez; Manuela Nebuloni; Davide Ottolina; Jonathan Montomoli; Luca Carsana; Tommaso Fossali; Antonio Castelli; Roberto Rech; Chiara Cogliati; Emanuele Catena; Riccardo Colombo
Journal:  Crit Care       Date:  2021-12-13       Impact factor: 9.097

Review 7.  The mechanisms of action of ivermectin against SARS-CoV-2-an extensive review.

Authors:  Asiya Kamber Zaidi; Puya Dehgani-Mobaraki
Journal:  J Antibiot (Tokyo)       Date:  2021-12-21       Impact factor: 2.649

8.  Physiologically Based Pharmacokinetic Modeling Approaches for Patients With SARS-CoV-2 Infection: A Case Study With Imatinib.

Authors:  Jeffry Adiwidjaja; Josephine A Adattini; Alan V Boddy; Andrew J McLachlan
Journal:  J Clin Pharmacol       Date:  2022-05-08       Impact factor: 2.860

9.  COVID-19: Multiorgan Dissemination of SARS-CoV-2 Is Driven by Pulmonary Factors.

Authors:  Akmaljon Odilov; Alexey Volkov; Adhamjon Abdullaev; Tatiana Gasanova; Tatiana Lipina; Igor Babichenko
Journal:  Viruses       Date:  2021-12-26       Impact factor: 5.048

10.  Mild Coronavirus Disease 2019 (COVID-19) Is Marked by Systemic Oxidative Stress: A Pilot Study.

Authors:  Larissa E van Eijk; Adriana Tami; Jan-Luuk Hillebrands; Wilfred F A den Dunnen; Martin H de Borst; Peter H J van der Voort; Marian L C Bulthuis; Alida C M Veloo; Karin I Wold; María F Vincenti González; Bernardina T F van der Gun; Harry van Goor; Arno R Bourgonje
Journal:  Antioxidants (Basel)       Date:  2021-12-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.